Showing results (1371-1380 of 1,689) with videos related to

Sort By:
Pageof 169
European Journal of Heart Failure|May 3, 2024
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fractionMingming Yang, Toru Kondo, Atefeh Talebi, et al.
Circulation. Heart Failure|October 27, 2023
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVERToru Kondo, Jawad H Butt, James P Curtain, et al.
JAMA Cardiology|March 28, 2026
Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical TrialHenri Lu, Annamaria Kosztin, Brian L Claggett, et al.
JAMA Cardiology|February 26, 2025
Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialJonathan W Cunningham, Safia Chatur, Brian L Claggett, et al.
Research Square|March 30, 2023
Unravelling specific diet and gut microbial contributions to inflammatory bowel diseaseGabriel Vasconcelos Pereira, Marie Boudaud, Mathis Wolter, et al.
European Heart Journal|May 23, 2023
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialSafia Chatur, Muthiah Vaduganathan, Brian Claggett, et al.
European Journal of Heart Failure|May 22, 2023
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trialSafia Chatur, Jonathan W Cunningham, Muthiah Vaduganathan, et al.
JACC. Heart Failure|December 6, 2025
Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure: The FINEARTS-HF TrialFinnian R Mc Causland, Safia Chatur, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|May 16, 2025
Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialMisato Chimura, Mingming Yang, Alasdair D Henderson, et al.
Frontiers in Cardiovascular Medicine|March 28, 2024
Contemporary approach to cardiogenic shock care: a state-of-the-art reviewAditya Mehta, Ilan Vavilin, Andrew H Nguyen, et al.
Pageof 169